Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 17:42
Terns Pharmaceuticals Market Cap: 491.80M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 485.00M |
| November 20, 2024 | 475.66M |
| November 19, 2024 | 501.99M |
| November 18, 2024 | 484.15M |
| November 15, 2024 | 524.07M |
| November 14, 2024 | 556.35M |
| November 13, 2024 | 575.89M |
| November 12, 2024 | 609.01M |
| November 11, 2024 | 633.64M |
| November 08, 2024 | 620.05M |
| November 07, 2024 | 599.51M |
| November 06, 2024 | 614.80M |
| November 05, 2024 | 608.85M |
| November 04, 2024 | 602.91M |
| November 01, 2024 | 589.32M |
| October 31, 2024 | 582.53M |
| October 30, 2024 | 585.08M |
| October 29, 2024 | 584.23M |
| October 28, 2024 | 552.81M |
| October 25, 2024 | 566.40M |
| October 24, 2024 | 573.19M |
| October 23, 2024 | 593.57M |
| October 22, 2024 | 636.88M |
| October 21, 2024 | 614.80M |
| October 18, 2024 | 629.24M |
| Date | Value |
|---|---|
| October 17, 2024 | 636.88M |
| October 16, 2024 | 649.62M |
| October 15, 2024 | 645.37M |
| October 14, 2024 | 647.07M |
| October 11, 2024 | 651.31M |
| October 10, 2024 | 628.81M |
| October 09, 2024 | 669.15M |
| October 08, 2024 | 663.20M |
| October 07, 2024 | 666.60M |
| October 04, 2024 | 702.26M |
| October 03, 2024 | 696.32M |
| October 02, 2024 | 696.32M |
| October 01, 2024 | 687.83M |
| September 30, 2024 | 708.21M |
| September 27, 2024 | 721.93M |
| September 26, 2024 | 747.26M |
| September 25, 2024 | 781.03M |
| September 24, 2024 | 811.43M |
| September 23, 2024 | 821.56M |
| September 20, 2024 | 846.05M |
| September 19, 2024 | 847.74M |
| September 18, 2024 | 862.09M |
| September 17, 2024 | 813.12M |
| September 16, 2024 | 794.54M |
| September 13, 2024 | 756.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
37.92M
Minimum
May 11 2022
862.09M
Maximum
Sep 18 2024
358.60M
Average
345.49M
Median
Jan 26 2024
Market Cap Benchmarks
| Eli Lilly and Co | 709.92B |
| Viking Therapeutics Inc | 5.864B |
| Biomarin Pharmaceutical Inc | 12.24B |
| Elite Pharmaceuticals Inc | 658.91M |
| Verrica Pharmaceuticals Inc | 45.60M |
Market Cap Related Metrics
| Price to Book Value | 1.349 |
| Price | 5.79 |
| Earnings Yield | -20.38% |